Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Medartis reported engagement with 274 surgeons and other clinicians in the states MedaRep covers, worth $680K in consulting, speaking, meals and travel for its device products, the most in California ($116K to 34). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($116K, 34 engaged), Texas ($104K, 37 engaged), New York ($76K, 11 engaged), North Carolina ($60K, 7 engaged), Mississippi ($59K, 1 engaged).
In the last ten years FDA made 24 decisions for Medartis (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2023 (5). The latest was on 2026-06-05.
| APTUS Elbow Dorsal Olecranon Plates |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Medartis.